Vanguard Group’s Sensei Biotherapeutics SNSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
29,090
-556,486
| -95% | -$4.77M | ﹤0.01% | 4051 |
|
|
2025
Q1 | $231K | Sell |
585,576
-8,878
| -1% | -$3.5K | ﹤0.01% | 4040 |
|
|
2024
Q4 | $291K | Sell |
594,454
-24,303
| -4% | -$11.9K | ﹤0.01% | 4048 |
|
|
2024
Q3 | $370K | Hold |
618,757
| – | – | ﹤0.01% | 4042 |
|
|
2024
Q2 | $384K | Buy |
618,757
+44,913
| +8% | +$27.9K | ﹤0.01% | 4066 |
|
|
2024
Q1 | $603K | Buy |
573,844
+193
| +0% | +$203 | ﹤0.01% | 3969 |
|
|
2023
Q4 | $397K | Hold |
573,651
| – | – | ﹤0.01% | 4098 |
|
|
2023
Q3 | $459K | Hold |
573,651
| – | – | ﹤0.01% | 4075 |
|
|
2023
Q2 | $654K | Hold |
573,651
| – | – | ﹤0.01% | 4033 |
|
|
2023
Q1 | $860K | Hold |
573,651
| – | – | ﹤0.01% | 3967 |
|
|
2022
Q4 | $855K | Buy |
573,651
+195
| +0% | +$291 | ﹤0.01% | 3958 |
|
|
2022
Q3 | $889K | Sell |
573,456
-96,116
| -14% | -$149K | ﹤0.01% | 4043 |
|
|
2022
Q2 | $1.52M | Sell |
669,572
-86,378
| -11% | -$196K | ﹤0.01% | 3932 |
|
|
2022
Q1 | $1.75M | Buy |
755,950
+2,255
| +0.3% | +$5.21K | ﹤0.01% | 4012 |
|
|
2021
Q4 | $4.37M | Buy |
753,695
+6,936
| +0.9% | +$40.2K | ﹤0.01% | 3687 |
|
|
2021
Q3 | $7.86M | Buy |
746,759
+359,006
| +93% | +$3.78M | ﹤0.01% | 3384 |
|
|
2021
Q2 | $3.78M | Buy |
387,753
+63,057
| +19% | +$615K | ﹤0.01% | 3735 |
|
|
2021
Q1 | $4.72M | Buy |
+324,696
| New | +$4.72M | ﹤0.01% | 3561 |
|